Discovering the latest non-invasive pain relief devices world-wide
SCENAR is a generic term describing a type of advanced TENS device. Originally from Russia, SCENAR Technology is now manufactured and used worldwide using different brands.
EVOLUTION of SCENAR
Devices and Therapy
1975 SCENAR signal first developed
1978 SCENAR treatments first began
1980’s Introduced to Russian Military & space organizations
1986 First device permitted in Russia for public treatment
1998 1st International seminar in the Bahamas
2003 SCENAR first used in Australia/USA/Canada
2004 USA companies begin production
2011 SCENAR first approved for sale by Health Canada
2014 SCENAR Deutschland first produce Key Series
2015 Key Series obtains CE + ARTG certification for Europe & Australia
Require More Information
1 855 972 3627
SCENAR technology relies on the body’s mechanism of adaptation ensuring dynamic equilibrium or, homeostasis. Regulation of the body’s vital functions is achieved through close connection and interaction of the nervous and endocrine systems. The effects of these systems results in the release of biologically active chemical modulators called neuromediators. Examples of these are acetylcholine, adrenaline and nor-adrenaline. Amino acids are another type of chemical modulator. These are important in activation of the thickly myelinated A- and B-neural fibres. Examples of this modulator include glutamine and asparagine. The largest group of chemical modulators are the neuromediators and include endorphins (the feel good chemical modulator), enkephalins and bradykinin.
In SCENAR therapy the most important chemical modulators are neuropeptides. These are the main modulator of neural activity of the thin non-myelinated, ‘difficult-to-excite’ C-fibres. These neuropeptide-producing nerve fibres make up more than 70% of the body’s neural tracts. C-fibre’s specific properties enable the production of a powerful analgesic effect, which is brought about by the release of neuropeptides, once the C-fibre is activated.
The main goal of SCENAR therapy is that a maximum number of C-fibres are activated to induce the secretion of a sufficient amount of neuropeptides. This is achieved by active feedback, bipolar electric impulse and individually dosed influence.
Biopolar Electric Impulses
The characteristics of the SCENAR impulse are such that the probability of excitation of the thin neuropeptide-secreting C-fibres is higher than conventional methods of electrotherapy.
The SCENAR enables a maximal part of the nervous tissue to be activated. This is necessary for the achievement of an optimal response from the patient’s body.
The electrical signals generated by the SCENAR device are similar in form to the body’s own endogenous neurological impulses. In this way the body does not recognise them as alien or invasive therefore negative side effects as a result of the therapy are virtually non-existent.
The optimum therapeutic results are always dependant upon the clients body’s response and therefore individual to each client. As the SCENAR device monitors treatment, results can be evaluated and the device also independently delivers the correct impulse driven by the body’s response, eliminating overdosing and hence few if any side effects.
The most unique characteristic of the SCENAR is that it can induce changes in the parameters of its impulse automatically and in accordance with the body’s response to the device. While conventional therapeutic devices are passive, the SCENAR device involves active reflex biofeedback, which means that the device communicates actively with the processes that are happening in the body.
The SCENAR device does this by monitoring the skin’s impedance and then changes the electric impulse it is sending out in accordance with the changes in the skin’s impedance. Therefore active reflex biofeedback means that maximal therapeutic effectiveness can be achieved.
Individually Dosed Influence
The SCENAR device can be used regardless of the type of diagnosis and is therefore a non-specific approach. However depending on the complaint or ailment of the client the therapist can choose the dosage of the SCENAR or the direction in which the SCENAR is applied.
Clinical experience with the SCENAR device has further indicated that the optimal therapeutic effect is achieved when there is a maximal variability of the impulse during treatment.
The optimum therapeutic results are always dependent upon the client’s body’s response and therefore individual to each client. As the SCENAR device monitors and evaluates treatment results it independently delivers the correct impulse without the possibility of overdosing and hence few side effects.
“During the Cold War the Russians created a method of treatment initially for their Cosmonauts with little or no use of drugs called SCENAR. It remained widely unknown until it ceased being a military secret after Perestroika in the late 1990’s.”
What is SCENAR?
SCENAR is a generic term describing a type of advanced TENS device. It is an acroynm for Self-Controlled-Energo-Neuro-Adaptive-Regulator.
The information contained in this site including but not limited to text, graphics, images, information, advice, links and/or any other material contained herein is for information and education purposes only. Read More
© 2016 Scenar Health Ltd